Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the... see more

TSX:EDT - Post Discussion

Spectral Medical Inc > Share Value Loss
View:
Post by Accountprince on Dec 13, 2022 10:45am

Share Value Loss

Spectral was full of opportunity and potential at the time Seto came on board.  The share price was in excess of $0.70 per share.  Paradigm had put a value of $2.00 per share that was revised to over $4.00 per share when the Baxter deal was announced.

Since then the share price has dropped to a pathetic $0.33 per share and today we find out we've lost 70% of the value of Dialco because he permitted and oversaw a non-compliance with the Infomed agreement.  That's the only facts reluctantly provided to shareholders.  Infomed are obviously prudent businessmen and with Swiss efficiency have scored 70% of Dialco for zero dollars.  Forget all the nice words in the press release - we are now a minority partner in our company at 30% after a forced giveaway of 70% and our fortunes with Dialco will be determined by Infomed acting on their own as majority.  A laughing stock to the market.

I don't see any value exhibited by management over the last 3 years.  Only loss of value.  Time to stop doing the same old thing hoping for a different outcome.  Time to sell our assets for the inherent value now before it's dissipated by incompetent management.
Comment by PezDalatoYou on Dec 13, 2022 11:16am
Fortunately, SP is flat on this PR. What's weird is that it's not like InfoMed has any big presence or pull in the US market to drive the clinical trial either. I guess this decision was all about funding the DIMI trial or Spectral's inability to raise funds for the trial? Because as per the June 7, 2021 PR, Spectral was going to outsource the trial to Cromsource so it's not like ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities